ES03: Advanced NSCLC: Further Precision Medicine Over Targeted Therapy
Tracks
Saigon 1 Ballroom
Friday, October 10, 2025 |
10:45 AM - 11:45 AM |
Details
This session will invite renowned Asian and international experts on clinical research to comprehensively, precisely present new concepts, cutting-edge knowledge, and significant research findings in NSCLC treatment, including EGFR, ALK, MET, and KRAS, thereby advancing precision medicine over targeted therapy, and maximizing the clinical benefits of NSCLC targeted therapy in Asia.
Presentations followed by panel discussion and audience Q&A.
Speaker
Tony Mok
Chinese University Of Hong Kong
Session Chair
10:45 AM - 10:47 AM
Myung-Ju Ahn
Samsung Medical Center
ES03.01: Current Landscape and Future Prospects of EGFR-Targeted Therapy
10:47 AM - 10:59 AM
Makoto Nishio
Cancer Institute Hospital | JFCR
ES03.02: Recent Advances and Future Strategies in ALK/ROS1-Targeted Therapy
10:59 AM - 11:11 AM
Ross Soo
National University Hospital
ES03.03: Challenges and Future Perspectives MET/HER2-Targeted Therapy
11:11 AM - 11:23 AM
Xiuning Le
MD Anderson Cancer Center
ES03.04: Advances in KRAS/RET-Targeted Therapy
11:23 AM - 11:35 AM